ghk-cu clinical trial “Is actually worth it?” is genuinely one of the most common questions in my comments, so let me finally answer it properly., The short version: copper peptides have real research behind them, GHK-Cu Repairing Serum | Barrier
Description
Vasoactive Intestinal Peptide (VIP) exerts its effects by binding to specific receptors, VPAC1 and VPAC2, which are widely expressed in various tissues

consult the drug's package insert to verify compatibility before use

VIP partially prevented the collapse of immune privilege in ex vivo hHFs induced by IFN-

It also suppresses the oxidation of low-density lipoprotein, quenches hydroxyl and other reactive oxygen species, and chelates iron in a manner that blocks iron-driven lipid peroxidation

Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F et al (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

A mixed basis set GEN (SDD basis sets for copper atom, and 631 + G (d,p) set for other atoms) was applied for all the calculations in this study
